netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Formulary Chapter 5: Infections - Full Chapter

Only high cost medicines to be supplied within our health economy are listed on BSW Formulary, but patients may also have access to more specialised, high cost medicines via other specialist centres, if eligible.


Infections Prescribing Guidance 

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

The Primary care antibiotic guidance can be found here

Management of Infection Quick Ref Guide for Adults can be found here

Management of Infection Quick Ref Guide for Children can be found here

Infections-related Shared Care Agreements

Please see our Shared Care Agreements page for all shared care agreements (SCAs) relating to this chapter

Lyme Disease:

Most up to date information see NICE Guideline NG95  April 2018 and for treatment regimens please see our primary care antibiotic guidance (link above).

Th NICE guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease.

For general information 

Out-patient Antibiotic Therapy (OPAT) services across BaNES/Swindon/Wiltshire:

GWH OPAT service:

OPAT Specialist Nurse - 01793 605032

Or alternatively contact switchboard on 01793 604020 and bleep 1108

OPAT Team working hours:

Monday to Friday 08:30am – 16:30pm

Out of hours contact:

Switchboard – 01793 604020 and bleep:

On call Orthopaedic registrar – 1088

On call Medical registrar – 3333

Other useful contact telephone numbers:

The PICC Team – 01793 605885 or bleep 2615

SEQOL – Swindon Community Nurses – 01793 646466

RUH OPAT service:

Direct line (with answerphone): 01225 821490

OR RUH switchboard and bleep 7467

Service is open Monday to Friday 8am to 4-4:30pm

NHSE Easy read information: Sepsis These easy read documents provide information about how to avoid sepsis, spotting the signs of sepsis, and problems after sepsis. 4/3/2020


Many of the products in this chapter are available for purchase over-the-counter, and patients are encouraged to self-care, with the support of their community pharmacist, in the first instance.

For further information on self-care & the NHS, please refer to

Chapter Links...
05.05.08  Expand sub section  Drugs for strongyloidiasis
View adult BNF View SPC online
Unlicensed Drug Unlicensed
  • Eskazole 400mg tablets (Imported (France)
  • Zentel 200mg chewable tablets (Imported (Australia)
  • Zentel 400mg chewable tablets (Imported (United States)
  • Dermatology use for cutaneous larva migrans
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Track Changes
Display tracking information
click to search
Link to adult BNF
click to search
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHS England
High Cost Drug Approval System

Traffic Light Status Information

Status Description


RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  


Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Amber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  


These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  


Suitable for patient to be directed to buy themselves  


Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   


Not currently used. We intend to include this TLS in future to highlight where a decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.  

Red Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.